Inhibition of lymphocyte-mediated cytotoxicity by Clostridium botulinum C3 transferase.
D036002:ADP Ribose Transferases / Q000378:metabolism* / Q000494:pharmacology*; D001692:Biological Transport; D001905:Botulinum Toxins; D002478:Cells, Cultured; D002860:Chromium Radioisotopes; D003014:Clostridium botulinum / Q000201:enzymology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D018274:Electroporation; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D009243:NAD / Q000378:metabolism
D002860:Chromium Radioisotopes; D007376:Interleukin-2; D009243:NAD; D036002:ADP Ribose Transferases; C063007:exoenzyme C3, Clostridium botulinum; D001905:Botulinum Toxins